Abstract
Fibroblast growth factor 23 (FGF23) was identified in 2000. Since then, FGF23 has been found to physiologically regulate phosphate metabolism and aberrant actions of FGF23 results in several disorders of phosphate and bone metabolism. In addition, FGF23 plays an important role in the development of chronic kidney disease-mineral and bone disorder. However, further investigations are necessary, especially with regard to the regulation of FGF23 expression. In this minireview, wefocus on the physiological and pathophysiological significance of FGF23 in phosphate and bone metabolism. Copyright © 2010 The Endocrine Society. All rights reserved.
Cite
CITATION STYLE
Hori, M., Shimizu, Y., & Fukumoto, S. (2011, January). Minireview: Fibroblast growth factor 23 in phosphate homeostasis and bone metabolism. Endocrinology. https://doi.org/10.1210/en.2010-0800
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.